ArticleDiabetes2025

Cannabinoid Receptor 2 Agonism Demonstrates Therapeutic Potential in Experimental Models of Relevance to Diabetic Retinopathy.

Cayla D Ontko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.